as on November 14, 2025 at 11:39 pm IST
Day's Low
Day's High
8.42%
Downside
0.55%
Upside
52 Week's Low
52 Week's High
59.52%
Downside
91.94%
Upside
Check Protara Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$204.5M
EPS (TTM)
-1.3475
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-59.4M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-49.42%
Compare market cap, revenue, PE, and other key metrics of Protara Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $204.5M | -75.47% | NA | 0.00% | |
| BUY | $59.8B | 235.01% | 1414.81 | 1.36% | |
| NA | $40.9B | NA | 712.21 | 1.38% | |
| BUY | $110.2B | 92.67% | 30.58 | 31.35% | |
| BUY | $71.6B | 22.7% | 16.34 | 32.13% |
The Protara Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Protara Therapeutics Inc investment value today
Current value as on today
₹2,16,822
Returns
₹1,16,822
(+116.82%)
Returns from Protara Therapeutics Inc Stock
₹1,11,628 (+111.63%)
Dollar Returns*
₹5,194 (+5.19%)
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Protara Therapeutics Inc. Average target price of $25
Get share price movements and forecasts by analysts on Protara Therapeutics Inc.
What analysts predicted
78.16%UPSIDE
Target Price
$25
Current Price
$5.46
Analyzed by
11 Analysts
Target
$25.00
Protara Therapeutics Inc target price $25, a slight upside of 78.16% compared to current price of $5.46. According to 11 analysts rating.
Search interest for Protara Therapeutics Inc Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, TARA stock has moved up by 22.8%
Best in 1 Year
![]()
In the last 1 year, TARA has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 81.5% return, outperforming this stock by 1.6%
| Organisation | Protara Therapeutics Inc |
| Headquarters | 345 Park Avenue South, New York, NY, United States, 10010 |
| Industry | Health Technology |
| CEO | Mr. Jesse Shefferman |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Patrick Fabbio M.B.A. | Chief Financial Officer |
Ms. Mary J. Grendell J.D. | General Counsel & Corporate Secretary |
Dr. Shane Williams Ph.D. | Chief People Officer |
Mr. Jesse Shefferman | Co-founder, CEO, President & Director |
Dr. Jacqueline Zummo M.B.A., M.P.H., Ph.D. | Co-Founder & Chief Scientific Operations Officer |
Dr. Leonardo Viana Nicacio M.D. | Chief Medical Officer |
Mr. William Conkling | Chief Commercial Officer |
Ms. Hannah Fry | VP, Principal Accounting Officer & Controller |
Ms. Justine O'Malley | Senior Vice President of Investor Relations & Corporate Affairs |
Protara Therapeutics Inc share price today is $5.46 as on . Protara Therapeutics Inc share today touched a day high of $5.49 and a low of $5.
Protara Therapeutics Inc share touched a 52 week high of $10.48 on and a 52 week low of $2.21 on . Protara Therapeutics Inc stock price today i.e. is trending at $5.46,which is 47.90% down from its 52 week high and 147.06% up from its 52 week low.
Protara Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Protara Therapeutics Inc (TARA) shares with as little as ₹88.7 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.00 in Protara Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Protara Therapeutics Inc share’s latest price of $5.46 as on November 14, 2025 at 11:39 pm IST, you will get 1.8315 shares of Protara Therapeutics Inc. Learn more about
fractional shares .
Protara Therapeutics Inc stock has given -75.47% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?